Stemtech annual free cash flow
2023
2024
2025
Stemtech Free Cash Flow (FCF) History (STEK)
Stemtech reported −$483,583 in free cash flow for fiscal 2025, an increase of $117,615 from the previous fiscal year, with a free cash flow margin of −16.81%.
View full Stemtech company overviewStemtech free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$483,583 | $117,615 | — | −16.81% |
| 2024 | 2024-12-31 | −$601,198 | $1.4M | — | −11.90% |
| 2023 | 2023-12-31 | −$2.0M | — | — | −41.37% |
Stemtech quarterly free cash flow
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$54,844 | −$129,796 | — | −8.71% |
| Q1 2026 | 2026-03-31 | −$425,883 | $284,624 | — | −91.99% |
| Q4 2025 | 2025-12-31 | $127,001 | $397,921 | — | +27.72% |
| Q3 2025 | 2025-09-30 | $24,971 | $1.2M | — | +2.93% |
| Q2 2025 | 2025-06-30 | $74,952 | $251,310 | — | +10.74% |
| Q1 2025 | 2025-03-31 | −$710,507 | −$1.7M | — | −81.85% |
| Q4 2024 | 2024-12-31 | −$270,920 | — | — | −20.62% |
| Q3 2024 | 2024-09-30 | −$1.2M | — | — | −113.55% |
| Q2 2024 | 2024-06-30 | −$176,358 | — | — | −13.30% |
| Q1 2024 | 2024-03-31 | $1.0M | — | — | +73.59% |
Stemtech free cash flow growth trends
Stemtech's latest reported quarter, Q2 2026, generated −$54,844 in free cash flow, a decrease of $129,796 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Stemtech filings at SEC.gov ↗